Embecta Corp. (EMBC) — Stock Price, Chart & Analysis
Embecta Corp. (EMBC) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $262.23M and a trailing P/E ratio of 3.01. Over the past 52 weeks, EMBC has traded between $2.77 and $15.55. Embecta Corp. pays a dividend yielding 13.1%. View the live EMBC chart, technical opinion, analyst ratings, fundamentals and latest news below.
Embecta Corp. (EMBC) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $262.23M |
| P/E ratio (TTM) | 3.01 |
| EPS (TTM) | $1.47 |
| Dividend yield | 13.1% |
| 52-week high | $15.55 |
| 52-week low | $2.77 |
| Beta | 0.79 |
| Avg. volume | 2.13M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Frequently asked questions about Embecta Corp. (EMBC)
How much does one share of Embecta Corp. cost?
As of the latest update, one share of Embecta Corp. (EMBC) trades at $100 (+0.00% today).
What is Embecta Corp.'s market cap?
Embecta Corp. has a market capitalization of approximately $262.23M.
What is Embecta Corp.'s P/E ratio?
Embecta Corp. has a trailing price-to-earnings (P/E) ratio of 3.01.
What is Embecta Corp.'s earnings per share (EPS)?
Embecta Corp.'s trailing twelve-month EPS is $1.47.
Does Embecta Corp. pay a dividend?
Yes — Embecta Corp. pays a dividend with a yield of 13.1% ($0.46 per share annually).
What is Embecta Corp.'s 52-week trading range?
Over the past year, EMBC has traded between $2.77 and $15.55.
What is the analyst price target for Embecta Corp.?
The mean analyst price target for Embecta Corp. is $4.00. This is informational only and not investment advice.
Latest Embecta Corp. (EMBC) news
- Embecta Corp (EMBC) (Q3 2026) Earnings Call Highlights: Strong Sequential Recovery and Raised ...News · Aug 7, 2026
- Embecta Q3 Earnings Call HighlightsNews · Aug 7, 2026
- Embecta Corp. Reports Third Quarter Fiscal 2026 Financial ResultsNews · Aug 7, 2026
- embecta Announces Quarterly Cash DividendNews · Aug 7, 2026
- embecta to Report Fiscal Third Quarter Financial ResultsNews · Jul 23, 2026
- Embecta (EMBC) Stock Fair Value Moves Lower As Analysts Reset Medtech ExpectationsNews · Jul 15, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live EMBC dashboard…